Template:Lymphadenopathy: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(13 intermediate revisions by 3 users not shown)
Line 28: Line 28:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Lymphadenopathy classification scheme|Classification]]
[[Lymphadenopathy historical perspective|Historical Perspective]]
|-
!
 
|- bgcolor="Pink"
!
[[Lymphadenopathy classification|Classification]]
|-  
|-  
!
!
Line 52: Line 58:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Lymphadenopathy epidemiology and demographics|Epidemiology & Demographics]]
[[Lymphadenopathy epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 70: Line 76:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Lymphadenopathy natural history|Natural History, Complications & Prognosis]]
[[Lymphadenopathy natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 82: Line 88:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Lymphadenopathy history and symptoms|History & Symptoms]]
[[Lymphadenopathy diagnostic criteria|Diagnostic Criteria]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Lymphadenopathy history and symptoms|History and Symptoms]]
|-  
|-  
!
!
Line 94: Line 106:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Lymphadenopathy laboratory tests|Laboratory Findings]]
[[Lymphadenopathy laboratory findings|Laboratory Findings]]
|-  
|-  
!
!
Line 100: Line 112:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Lymphadenopathy x ray|X - Ray]]
[[Lymphadenopathy electrocardiogram|Electrocardiogram]]
|-  
|-  
!
!
Line 106: Line 118:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Lymphadenopathy CT|CT]]
[[Lymphadenopathy x ray|X Ray]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Lymphadenopathy CT scan|CT scan]]
|-  
|-  
!
!
Line 156: Line 174:
[[Lymphadenopathy primary prevention|Primary Prevention]]
[[Lymphadenopathy primary prevention|Primary Prevention]]
|-  
|-  
!


!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Lymphadenopathy secondary prevention|Secondary Prevention]]
[[Lymphadenopathy secondary prevention|Secondary Prevention]]
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
Line 174: Line 192:
[[Lymphadenopathy future or investigational therapies|Future or Investigational Therapies]]
[[Lymphadenopathy future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!
!  


|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"
Line 184: Line 202:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Lymphadenopathy|Case #1]]
[[Lymphadenopathy case study one|Case #1]]
|-  
|-  
!
!
Line 249: Line 267:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://www.guideline.gov/search/searchresults.aspx?Type=3&txtSearch={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&num=20USNational Guidelines Clearinghouse]
[http://www.guideline.gov/search/searchresults.aspx?Type=3&txtSearch={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&num=20 US National Guidelines Clearinghouse]
|-  
|-  
!  
!  
Line 279: Line 297:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on{{PAGENAME}}]</small>
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]
|-  
|-  
!  
!  
Line 285: Line 303:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Lymphadenopathy}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wlDirections to Hospitals Treating Lymphadenopathy]
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Lymphadenopathy}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating Lymphadenopathy]
|-  
|-  
!  
!  

Latest revision as of 16:03, 28 January 2019

Lymphadenopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphadenopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphadenopathy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphadenopathy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphadenopathy

CDC on Lymphadenopathy

Lymphadenopathy in the news

Blogs on Lymphadenopathy

Directions to Hospitals Treating Lymphadenopathy

Risk calculators and risk factors for Lymphadenopathy

Retrieved from "https://www.wikidoc.org/index.php?title=Template:Lymphadenopathy&oldid=1542249"